Toxicology & Substance Abuse

Clonazepam (CLO) One Step Rapid Drug Test Device (Urine)

Powered by NomoFlow™

Results in 5 minutes Easy to use Highly sensitive

Rapid immunochromatographic assay for the qualitative detection of Clonazepam (CLO) and its metabolite 7-aminoclonazepam in urine.

A Foundation of Trust

Powered by NomoFlow™
CE
Marked
ISO 13485

Why Choose Our Clonazepam Rapid Test Device?

Our Clonazepam Rapid Test Device provides a fast and convenient method for detecting Clonazepam and its metabolite, 7-aminoclonazepam. With its high sensitivity and specificity, it delivers reliable results in minutes, making it an essential tool for drug screening programs and clinical toxicology.

Inside NomoFlow™: The Source of This Test's Superior Performance

The Clonazepam Rapid Test Device demonstrates excellent clinical performance in detecting Clonazepam and 7-aminoclonazepam in urine samples.

Clinical Performance Data

Analyte Sensitivity (PPA) Specificity (NPA) Overall Agreement
Clonazepam 95.8% (95% CI: 88.2 - 99.0%) 99.3% (95% CI: 97.7 - 99.9%) 99.0%
7-aminoclonazepam 94.5% (95% CI: 85.8 - 98.4%) 98.9% (95% CI: 97.0 - 99.7%) 98.5%

Relevant studies and publications will be available here soon.

Time to Result 5 minutes
Sample Type Urine
Cut-off 100 ng/mL
Kit Size 25 Tests/Kit
Format Device
Storage Conditions 2-30u00b0C
Shelf Life 24 months
Included Materials Test devices, Package insert
Required Materials (Not Included) Urine collection container, Timer
Certifications CE, ISO 13485

1

Collect Sample

Collect urine sample in a clean, dry container.

2

Apply Sample

Add 3 drops of urine to the sample well of the test device.

3

Read Results

Read the results at 5 minutes. Do not interpret after 10 minutes.

Product Information

  • Catalog Number: DOA-CLOUD
  • Product Name: Clonazepam (CLO) One Step Rapid Drug Test Device (Urine)

Download product documents for the Clonazepam Rapid Test Device.

Support

Frequently Asked Questions

Direct answers regarding clinical performance, workflow, and logistics.

The cut-off level for the Clonazepam Rapid Test is 100 ng/mL.
The test demonstrates high accuracy with a sensitivity of 95.8% for Clonazepam and 94.5% for 7-aminoclonazepam.

Have more specific technical or clinical questions?

Connect with a Clinical Application Specialist

For Clinical Professionals

Integrate into a Complete Respiratory Workflow

This test is a key component of a broader strategy for managing respiratory outbreaks, optimizing resource allocation, and improving patient outcomes. See how it fits into a complete workflow solution.

Explore Workflow Solutions

For Strategic Partners

Inject the Power of NomoFlow™ into Your Brand

Build your brand on our foundation of verifiable reliability. Our platform is available for OEM/ODM partnerships, offering superior products with complete manufacturing transparency.

Discover Partnership Value

Take the Next Step Towards Verifiable Reliability

Equip your facility with diagnostic tools engineered for certainty. Select your path below to get started.

Experience the Difference

Request evaluation samples for your laboratory validation.

Request Samples

Clinical Consultation

Discuss workflow integration with an application specialist.

Contact Support

Commercial Partnership

Inquire about distribution or OEM/ODM opportunities.

Become a Partner